Health
FDA conditionally approves first oral treatment for dogs with lymphoma – News-Medical.Net
Today, the U.S. Food and Drug Administration conditionally approved Laverdia-CA1 (verdinexor tablets) to treat dogs with lymphoma, a type of cancer of the lymph…
Today, the U.S. Food and Drug Administration conditionally approved Laverdia-CA1 (verdinexor tablets) to treat dogs with lymphoma, a type of cancer of the lymph nodes and lymphatic system. Laverdia-CA1 works to prevent certain proteins from leaving the nucleus of cancer cells, thereby allowing these proteins to control the growth and prevent the spread of cancerous cells in dogs.
Laverdia-CA1 is the first conditionally approved oral treatment for dogs with lymphoma. Because Laverdia-CA1 is orally…
-
Noosa News20 hours agoTeenager sentenced to 12 years for ‘heinous’ Acacia Ridge murder
-
Noosa News18 hours agoGirl’s death in a Queensland cult
-
General17 hours agoTeen driver on cocaine racing to Perth nightclub before high-speed crash that killed Nick Campo, court hears
-
Noosa News17 hours agoAirbnb owner hit with disturbing email after house trashed by hundreds of teens